A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Study of HL-085 in NRAS Mutant Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Safety Study of SGN-CD47M in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dietary Intervention in Patients with a History of Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
- Status
- COMPLETED
- Phase
- NA
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- N/A
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
- Status
- COMPLETED
- Phase
- N/A
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- Status
- RECRUITING
- Phase
- NA
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)
- Status
- SUSPENDED
- Phase
- PHASE1
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
High-Risk Skin Cancers With Atezolizumab Plus NT-I7
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.
- Status
- COMPLETED
- Phase
- NA
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1